Related Experiment Video
Updated: Dec 7, 2025

Cholesterol Efflux Assay
Published on: March 6, 2012
Regulation of ATP binding cassette transporter A1 (ABCA1) expression: cholesterol-dependent and - independent
Patrick He1,2, Ingrid C Gelissen3, Alaina J Ammit4,5
1Woolcock Emphysema Centre, Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia.
Insights
ATP binding cassette transporter A1 (ABCA1) plays a key role in inflammation. Understanding ABCA1 regulation in inflammatory lung diseases could lead to new therapeutic targets for conditions like asthma and COPD.
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- ATP binding cassette transporter A1 (ABCA1) is crucial for lipid homeostasis and has emerged as a key modulator of inflammation in chronic diseases.
- Its role in cardiovascular disease is well-documented, with growing evidence highlighting its beneficial effects in other inflammatory conditions.
- ABCA1 is recognized as a potential therapeutic target for diseases where inflammation is a central pathogenic mechanism.
Purpose of the Study:
- To review the signaling pathways regulating ABCA1 expression in the context of chronic inflammatory lung diseases.
- To explore both cholesterol-dependent and cholesterol-independent pathways influencing ABCA1.
- To identify potential therapeutic targets for inflammatory lung conditions based on ABCA1 regulation.
Main Methods:
- Literature review of studies on ABCA1 signaling pathways.
- Analysis of research linking ABCA1 to cardiovascular disease and inflammatory lung diseases.
- Synthesis of information on cholesterol-mediated and independent ABCA1 regulation.
Main Results:
- Cholesterol-mediated ABCA1 signaling pathways are well-defined, particularly from atherosclerosis research, and appear relevant to respiratory diseases.
- Cholesterol-independent signaling pathways that modulate ABCA1 expression in inflammatory lung disease are less understood.
- Various signaling pathways and ligands associated with ABCA1 regulation have been identified.
Conclusions:
- ABCA1 is a significant factor in chronic inflammatory lung diseases like asthma and COPD.
- Further understanding of ABCA1's cholesterol-independent regulation is needed for this clinical context.
- Targeting ABCA1 signaling pathways offers potential therapeutic strategies for inflammatory lung diseases.
Abstract:
The role of the ATP binding cassette transporter A1 (ABCA1) in maintaining cellular lipid homeostasis in cardiovascular disease is well established. More recently, the important beneficial role played by ABCA1 in modulating pathogenic disease mechanisms, such as inflammation, in a broad range of chronic conditions has been realised. These studies position ABCA1 as a potential therapeutic target in a diverse range of diseases where inflammation is an underlying cause. Chronic respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD) are driven by inflammation, and as such, there is now a growing recognition that we need a greater understanding of the signaling pathways responsible for regulation of ABCA1 expression in this clinical context. While the signaling pathways responsible for cholesterol-mediated ABCA1 expression have been clearly delineated through decades of studies in the atherosclerosis field, and thus far appear to be translatable to the respiratory field, less is known about the cholesterol-independent signaling pathways that can modulate ABCA1 expression in inflammatory lung disease. This review will identify the various signaling pathways and ligands that are associated with the regulation of ABCA1 expression and may be exploited in future as therapeutic targets in the setting of chronic inflammatory lung diseases.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Regulation of Angiogenesis and Blood Supply
Regulation of Nuclear Protein Sorting
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Regulation of Expression at Multiple Steps

